Patents by Inventor Rainer Ng

Rainer Ng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240109071
    Abstract: A method of thermal cycling a droplet, including providing a droplet actuator with heaters establishing a first thermal zone and second thermal zone in a substantially oil-filled droplet operations gap; a thermal cycling path comprising droplet operations electrodes comprising a first droplet operations electrode in the first thermal zone and a second droplet operations electrode in the second thermal zone, wherein the first and second droplet operations electrodes are within 5 mm of each other; a first temperature at the first droplet operations electrode and a second temperature at the second droplet operations electrode, wherein the first and second temperatures differ by at least about 10° C.; and using the droplet operations electrodes, transporting the droplet in a cycling pattern for multiple cycles along the thermal cycling path between the first droplet operations electrode and the second droplet operations electrode. Cartridges and systems are also provided.
    Type: Application
    Filed: December 1, 2023
    Publication date: April 4, 2024
    Applicant: Baebies, Inc.
    Inventors: Daniel Wu, Rainer Ng, Greg Smith, Vijay Srinivasan, Vamsee Pamula
  • Publication number: 20230304066
    Abstract: A method for assaying analytes in a blood sample by loading a blood sample onto a microfluidic device; combining the blood sample with a buffer reagent comprising a surfactant to provide a diluted blood sample and conduct an assay. The surfactant is selected to permit the use of electrowetting to conduct droplet operations using the blood sample and to permit the use of a fluorescence-based droplet operation. The assay may be an unbound bilirubin assay.
    Type: Application
    Filed: September 7, 2021
    Publication date: September 28, 2023
    Applicant: Baebies, Inc.
    Inventors: Michael A. BASMAJIAN, Jennifer ELDERBROOM, Maithri KRISHNAMURTHY, Erik BURDE, Michael BOSO, Daniel Hull, Rainer NG, Vijay SRINIVASAN, Ramakrishna SISTA, Vamsee PAMULA
  • Publication number: 20230194540
    Abstract: Systems and methods for measuring hemoglobin, G6PD activity, and or bilirubin activity in a sample, including measuring the absorbance of a sample, removing background interfering signals, and quantifying the relevant analyte. Systems and methods for reconstituting a reagent in a droplet actuator. Systems and methods for separating plasma from a whole blood sample on a droplet actuator, including combining a sample droplet with an agglutination reagent droplet and using a novel combination of droplet operations to split the sample into a plasma and an agglutinated red blood cell fraction.
    Type: Application
    Filed: May 17, 2021
    Publication date: June 22, 2023
    Applicant: Baebies, Inc.
    Inventors: Michael A. Basmajian, Rainer Ng, Miriam H. Nuffer, Jennifer Elderbroom, Michael Boso, Christopher Roberts, Ramakrishna Sista, Vijay Srinivasan, Allen E. Eckhardt, Vamsee K. Pamula
  • Patent number: 9107940
    Abstract: The present invention relates to compositions and methods for treating and preventing skeletal muscle deficiencies. In particular, the present invention provides compositions comprising poloxamers (e.g., poloxamer 188-P188) and methods of using the same for treating and preventing skeletal muscle deficiencies and injuries (e.g., dystrophin-deficient skeletal muscle; skeletal muscle having a contraction force deficit; skeletal muscle having a Ca2+ imbalance; skeletal muscle having microtears).
    Type: Grant
    Filed: October 7, 2014
    Date of Patent: August 18, 2015
    Assignees: The Regents of the University of Michigan, Phrixus Pharmaceuticals, Inc.
    Inventors: Rainer Ng, Joseph M. Metzger, Lorraine Reeve, Bruce Markham
  • Publication number: 20150030559
    Abstract: The present invention relates to compositions and methods for treating and preventing skeletal muscle deficiencies. In particular, the present invention provides compositions comprising poloxamers (e.g., poloxamer 188-P188) and methods of using the same for treating and preventing skeletal muscle deficiencies and injuries (e.g., dystrophin-deficient skeletal muscle; skeletal muscle having a contraction force deficit; skeletal muscle having a Ca2+ imbalance; skeletal muscle having microtears).
    Type: Application
    Filed: October 7, 2014
    Publication date: January 29, 2015
    Inventors: Rainer Ng, Joseph M. Metzger, Lorraine Reeve, Bruce Markham
  • Patent number: 8852568
    Abstract: The present invention relates to compositions and methods for treating and preventing skeletal muscle deficiencies. In particular, the present invention provides compositions comprising poloxamers (e.g., poloxamer 188-P188) and methods of using the same for treating and preventing skeletal muscle deficiencies and injuries (e.g., dystrophin-deficient skeletal muscle; skeletal muscle having a contraction force deficit; skeletal muscle having a Ca2+ imbalance; skeletal muscle having microtears).
    Type: Grant
    Filed: December 17, 2008
    Date of Patent: October 7, 2014
    Assignees: The Regents of the University of Michigan, Phrixus Pharmaceuticals, Inc.
    Inventors: Rainer Ng, Joseph M. Metzger, Lorraine Reeve, Bruce Markham
  • Publication number: 20110033412
    Abstract: The present invention relates to compositions and methods for treating and preventing skeletal muscle deficiencies. In particular, the present invention provides compositions comprising poloxamers (e.g., poloxamer 188-P188) and methods of using the same for treating and preventing skeletal muscle deficiencies and injuries (e.g., dystrophin-deficient skeletal muscle; skeletal muscle having a contraction force deficit; skeletal muscle having a Ca2+ imbalance; skeletal muscle having microtears).
    Type: Application
    Filed: December 17, 2008
    Publication date: February 10, 2011
    Applicants: THE REGENTS OF THE UNIVERSITY OF MICHIGAN, PHRIXUS PHARMACEUTICALS, INC.
    Inventors: Rainer Ng, Joseph M. Metzger, Lorraine Reeve, Bruce Markham